Company Search:
Advanced Search
Sponsored Links
Kopran Limited Company Snapshot
Kopran Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kopran Limited with three other companies in this sector in India: RPG Life Sciences Limited (2018 sales of 3.44 billion Indian Rupees [US$49.53 million] ), Albert David Limited (2.87 billion Indian Rupees [US$41.39 million] ), and Advanced Enzyme Technologies Ltd (3.91 billion Indian Rupees [US$56.31 million] ).

Sales Analysis. During the year ended March of 2018, sales at Kopran Limited were 3.15 billion Indian Rupees (US$45.32 million). This is a very small increase of 1.6% versus 2017, when the company's sales were 3.10 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kopran Limited
  Stock Performance Chart for Kopran Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 40.25
(Figures in Indian Rupees)
1 Week -1.8%   13 Weeks -0.7%  
4 Weeks -3.2%   52 Weeks -42.9%  
Kopran Limited Key Data:
  Ticker: KOPRAN Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 3,147,079,000
(Year Ending Jan 2019).
Employees: 347
  Currency: Indian Rupees Market Cap: 1,740,768,225
  Fiscal Yr Ends: March Shares Outstanding: 43,248,900
  Share Type: Ordinary Closely Held Shares: 17,888,959
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.